PCSK9 Inhibitors Evaluation (ID: i726a) Question Title * 1. How many patients with hypercholesterolemia do you currently manage in your practice? Please respond with your best approximate number. Question Title * 2. How many years have you been in practice? <1 1-10 11-20 > 21 Question Title * 3. How confident are you in your ability to access PCSK9i for your patients when indicated? Very confident Confident Neutral Unconfident Very unconfident Question Title * 4. Which of the following best describes the impact of this activity on your performance? I gained new strategies/skills/information that I can apply to my area of practice I need more information before I change my practice behavior This activity will not change my practice, as my current practice is consistent with the information presented This activity will not change my practice, as I do not agree with the information presented Question Title * 5. How committed are you to making changes in your practice based on your participation in this activity? Very committed Committed Neutral Not committed I do not plan to make changes. Question Title * 6. After participating in today’s activity, I am now able to: Strongly agree Agree Neutral Disagree Strongly disagree Summarize the findings from CV outcomes studies of PCSK9i Summarize the findings from CV outcomes studies of PCSK9i Strongly agree Summarize the findings from CV outcomes studies of PCSK9i Agree Summarize the findings from CV outcomes studies of PCSK9i Neutral Summarize the findings from CV outcomes studies of PCSK9i Disagree Summarize the findings from CV outcomes studies of PCSK9i Strongly disagree Identify specific patient populations that would benefit from LDL-C lowering Identify specific patient populations that would benefit from LDL-C lowering Strongly agree Identify specific patient populations that would benefit from LDL-C lowering Agree Identify specific patient populations that would benefit from LDL-C lowering Neutral Identify specific patient populations that would benefit from LDL-C lowering Disagree Identify specific patient populations that would benefit from LDL-C lowering Strongly disagree Apply the guidance from the latest clinical recommendations for the use of PCSK9i Apply the guidance from the latest clinical recommendations for the use of PCSK9i Strongly agree Apply the guidance from the latest clinical recommendations for the use of PCSK9i Agree Apply the guidance from the latest clinical recommendations for the use of PCSK9i Neutral Apply the guidance from the latest clinical recommendations for the use of PCSK9i Disagree Apply the guidance from the latest clinical recommendations for the use of PCSK9i Strongly disagree Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i Strongly agree Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i Agree Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i Neutral Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i Disagree Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i Strongly disagree Question Title * 7. James A. Underberg MS, MD, FACP, FNLA, effectively: Strongly agree Agree Neutral Disagree Strongly disagree Presented the material Presented the material Strongly agree Presented the material Agree Presented the material Neutral Presented the material Disagree Presented the material Strongly disagree Avoided commercial bias Avoided commercial bias Strongly agree Avoided commercial bias Agree Avoided commercial bias Neutral Avoided commercial bias Disagree Avoided commercial bias Strongly disagree Question Title * 8. Kevin C. Maki, PhD, effectively: Strongly agree Agree Neutral Disagree Strongly disagree Presented the material Presented the material Strongly agree Presented the material Agree Presented the material Neutral Presented the material Disagree Presented the material Strongly disagree Avoided commercial bias Avoided commercial bias Strongly agree Avoided commercial bias Agree Avoided commercial bias Neutral Avoided commercial bias Disagree Avoided commercial bias Strongly disagree Question Title * 9. The content presented: Strongly agree Agree Neutral Disagree Strongly disagree Enhanced my current knowledge base Enhanced my current knowledge base Strongly agree Enhanced my current knowledge base Agree Enhanced my current knowledge base Neutral Enhanced my current knowledge base Disagree Enhanced my current knowledge base Strongly disagree Addressed my most pressing questions Addressed my most pressing questions Strongly agree Addressed my most pressing questions Agree Addressed my most pressing questions Neutral Addressed my most pressing questions Disagree Addressed my most pressing questions Strongly disagree Promoted improvements or quality in health care Promoted improvements or quality in health care Strongly agree Promoted improvements or quality in health care Agree Promoted improvements or quality in health care Neutral Promoted improvements or quality in health care Disagree Promoted improvements or quality in health care Strongly disagree Was scientifically rigorous and evidence based Was scientifically rigorous and evidence based Strongly agree Was scientifically rigorous and evidence based Agree Was scientifically rigorous and evidence based Neutral Was scientifically rigorous and evidence based Disagree Was scientifically rigorous and evidence based Strongly disagree Avoided commercial bias or influence Avoided commercial bias or influence Strongly agree Avoided commercial bias or influence Agree Avoided commercial bias or influence Neutral Avoided commercial bias or influence Disagree Avoided commercial bias or influence Strongly disagree Question Title * 10. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice? Question Title * 11. What barriers do you see to making changes in your practice? Question Title * 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: Question Title * 13. If you indicated that you perceived commercial bias or influence, please describe: Done